A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus

NCT01952145 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

557

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/liraglutide
DRUG: insulin glargine

Sponsor

Novo Nordisk A/S